JUPITER NEUROSCIENCES, INC. Sale of Stock, Price Per Share
JUPITER NEUROSCIENCES, INC. (JUNS) had Sale of Stock, Price Per Share of $36.34 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2026-08-14
- 2026-06-30: Sale of Stock, Price Per Share $36.34.
- 2026-03-31: Sale of Stock, Price Per Share $0.84.
- 2025-12-31: Sale of Stock, Price Per Share $1.11.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2026-06-30 | $36.34 10-Q · filed 2026-08-14 |
| 2026-03-31 | $0.84 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.11 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |